This was the stock's third consecutive day of losses.

Investors in DXC Technology Co (Symbol: DXC) saw new options become available today, for the May 16th expiration. One of the key data points that goes into the price an option buyer is willing to ...

Stifel Nicolaus analyst David Grossman maintained a Hold rating on DXC Technology (DXC – Research Report) today and set a price target of $24.00. The company’s shares closed yesterday at $22.61.

ASHBURN, Va., Feb. 27, 2025 /PRNewswire/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Pat McClanahan as Global ...

Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...

Investors in DXC Technology Company (NYSE:DXC) had a good week, as its shares rose 3.8% to close at US$22.35 following the release of its quarterly results. Revenues were US$3.2b, approximately in ...

Shares of DXC Technology Co. DXC slipped 3.94% to $18.55 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.37% ...

ASHBURN, Va., Feb. 27, 2025 /CNW/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Pat McClanahan as Global Leader of ...

BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry ...